Supporting Biotech on their Commercialisation Pathway to Maximise Value from Early Clinical Development to Launch.
With Genchromes team of experienced pharmaceutical experts, we provide commercial & access support to biotech all along the lifecycle from preclinical, phase I,II,II to launch. 🧬
Our Vision - Throughout our experience, we noticed 3 main trends:
1. Nearly half of biotech launches underperformed.
2. Launch Pioneers, despite high level of innovation are overall less successful than established market innovators
3. New biotech launching themselves generally achieve lower sales than in partnership with pharma
With our team of international experts with strong pharmaceutical expertise, we want to help you avoid making these mistakes.
What We Do:
- New Product Launch
- Launch Planning
- Portfolio Planning
- BD and M&A
- Payers
- Pharma Partnerships
Our Fields Of Expertise From Pre-launch To Launch:
- Orphan
- Neurology
- Hemato-Oncology
- Oncology
- Biosimilars
- Hematology
- Infectiology
- Immunology & Inflammation
- Cardiovascular
- Nephrology
- Ophtalmology
For more information, please contact us at: contact@genchrome.com
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2022
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Genchrome founded?
Genchrome was founded in 2022.
What industry is Genchrome in?
Genchrome operates in Business Consulting and Services. Find similar Business Consulting and Services investors on gritt.io.
Where is Genchrome based?
Genchrome is headquartered in London, United Kingdom.
Find investors for your startup like Genchrome
Gritt sends AI-personalised outreach to each investor — from your Gmail
